Show simple item record

 
dc.contributorDepartament de Salut
dc.date.accessioned2018-10-29T13:37:10Z
dc.date.available2018-10-29T13:37:10Z
dc.date.issued2017-11-17
dc.identifier.citationTeduglutida per al tractament de la síndrome de l'intestí curt. Barcelona: Servei Català de la Salut; 2017.
dc.identifier.urihttp://hdl.handle.net/11351/3637
dc.descriptionTeduglutida; Short bowel syndrome; Treatment
dc.description.abstractShort Intestinal Syndrome (SIC) is a complex minority condition caused by the functional or anatomical loss of large intestinal segments that seriously compromise the absorption capacity. The most common aetiology in adults are surgical resections, either for mesenteric ischaemia, traumatism, radiation enteritis, Crohn's disease or bowel obstruction. In children, the main causes of SIC are congenital and perinatal diseases such as necrotizing enterocolitis, defects in the abdominal wall and Hirschsprung disease, among others
dc.language.isocat
dc.publisherServei Català de la Salut
dc.relation.ispartofPrograma d'harmonització farmacoteràpeutica, Servei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectIntestins - Obstruccions
dc.subjectIntestins - Malalties - Tractament
dc.subjectMedicaments - Assaigs clínics
dc.subject.meshShort Bowel Syndrome
dc.subject.mesh/drug therapy
dc.subject.meshDrug Evaluation
dc.titleTeduglutida per al tractament de la síndrome de l'intestí curt
dc.typeinfo:eu-repo/semantics/report
dc.subject.decssíndrome del intestino corto
dc.subject.decs/tratamiento farmacológico
dc.subject.decsevaluación de medicamentos
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record